Comparison of the therapeutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of the therapeutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia

Published:2008-04-04 Issue:5 Volume:24 Page:1407-1415
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Krivoshiev Stefan¹,Todorov Vasil V.²,Manitius Jacek³,Czekalski Stanislaw⁴,Scigalla Paul⁵,Koytchev Rossen⁶,

Affiliation:

1. Multidisciplinary Hospital for Active Treatment ‘Queen Giovanna’ Ltd. SofiaBulgaria

2. Multidisciplinary Hospital for Active Treatment ‘Pleven’ Ltd. PlevenBulgaria

3. Clinic of Nephrology Hypertension and Internal Diseases, BydgoszczPoland

4. Department of NephrologyTransplantation and Internal Diseases, Poznań University of Medical Sciences PoznańPoland

5. Principal Investigator, ICRC – International Clinical Research Consulting BerlinGermany

6. CRO, CCDRD AG NeuenhagenGermany

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079908X297402

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

2. Biosimilar erythropoietin in anemia treatment (BEAT)—Efficacy and safety of a 1:1 dose conversion from EPREX® to EPIAO® in patients with end-stage renal disease on hemodialysis: A prospective, randomized, double blind, parallel group study;Medicine;2022-11-25

3. Effectiveness of biosimilar drugs in the treatment of renal anemia: A case series;Medwave;2021-10-20

4. Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease;Kidney International Reports;2019-09

5. Biosimilars: An Approach to some Current Worldwide Regulation Frameworks;Current Clinical Pharmacology;2019-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3